393 related articles for article (PubMed ID: 24247011)
1. Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies.
Juárez-Jiménez J; Mendes E; Galdeano C; Martins C; Silva DB; Marco-Contelles J; do Carmo Carreiras M; Luque FJ; Ramsay RR
Biochim Biophys Acta; 2014 Feb; 1844(2):389-97. PubMed ID: 24247011
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives.
Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Petzer JP; Firgang SI; Suponitsky KY
Bioorg Med Chem Lett; 2015 Mar; 25(6):1206-11. PubMed ID: 25701250
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
Choi JW; Jang BK; Cho NC; Park JH; Yeon SK; Ju EJ; Lee YS; Han G; Pae AN; Kim DJ; Park KD
Bioorg Med Chem; 2015 Oct; 23(19):6486-96. PubMed ID: 26337020
[TBL] [Abstract][Full Text] [Related]
4. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
[TBL] [Abstract][Full Text] [Related]
6. The FAD binding sites of human monoamine oxidases A and B.
Edmondson DE; Binda C; Mattevi A
Neurotoxicology; 2004 Jan; 25(1-2):63-72. PubMed ID: 14697881
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure.
Hynson RM; Wouters J; Ramsay RR
Biochem Pharmacol; 2003 Jun; 65(11):1867-74. PubMed ID: 12781338
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
[TBL] [Abstract][Full Text] [Related]
10. Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties.
Yelekçi K; Karahan O; Toprakçi M
J Neural Transm (Vienna); 2007; 114(6):725-32. PubMed ID: 17401533
[TBL] [Abstract][Full Text] [Related]
11. Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Lourens AC; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Dec; 22(24):7367-70. PubMed ID: 23122857
[TBL] [Abstract][Full Text] [Related]
12. Spectrometric evidence for the flavin-1-phenylcyclopropylamine inactivator adduct with monoamine oxidase N.
Mitchell DJ; Nikolic D; Rivera E; Sablin SO; Choi S; van Breemen RB; Singer TP; Silverman RB
Biochemistry; 2001 May; 40(18):5447-56. PubMed ID: 11331009
[TBL] [Abstract][Full Text] [Related]
13. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
15. cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.
Malcomson T; Yelekci K; Borrello MT; Ganesan A; Semina E; De Kimpe N; Mangelinckx S; Ramsay RR
FEBS J; 2015 Aug; 282(16):3190-8. PubMed ID: 25755053
[TBL] [Abstract][Full Text] [Related]
16. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase by benzoxathiolone analogues.
Mostert S; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2016 Feb; 26(4):1200-4. PubMed ID: 26821818
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking of inhibitors into monoamine oxidase B.
Harkcom WT; Bevan DR
Biochem Biophys Res Commun; 2007 Aug; 360(2):401-6. PubMed ID: 17597580
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives.
Okaecwe T; Swanepoel AJ; Petzer A; Bergh JJ; Petzer JP
Bioorg Med Chem; 2012 Jul; 20(14):4336-47. PubMed ID: 22705191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
